Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.78 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.78 |
| ▸ | NQO2 | P16083 | 3/20 | 0.60 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.60 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA3 | P07451 | 1/20 | 0.59 |
| ▸ | TYR | P14679 | 1/20 | 0.59 |
| ▸ | DRD1 | P21728 | 1/20 | 0.59 |
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
| ▸ | CA6 | P23280 | 1/20 | 0.59 |
| ▸ | CA5A | P35218 | 1/20 | 0.59 |
| ▸ | CA7 | P43166 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL901031 | 1.00 | ESR1 (0.78) | ESR1ESR2NQO2PTGS1PTGS2 | |
| SCHEMBL901098 | 1.00 | ESR1 (0.78) | ESR1ESR2NQO2PTGS1PTGS2 | |
| SCHEMBL901099 | 1.00 | ESR1 (0.78) | ESR1ESR2NQO2PTGS1PTGS2 | |
| SCHEMBL901112 | 0.92 | ALDH1A1 (0.68) | ESR1ESR2ALDH1A1POLBGLA | |
| SCHEMBL901113 | 0.92 | ALDH1A1 (0.68) | ESR1ESR2ALDH1A1POLBGLA | |
| SCHEMBL9036138 | 0.88 | ESR1 (1.00) | ESR1ESR2NQO2PTGS1PTGS2 | |
| SCHEMBL9036145 | 0.88 | ESR1 (1.00) | ESR1ESR2NQO2PTGS1PTGS2 | |
| SCHEMBL375018 | 0.88 | ESR1 (1.00) | ESR1ESR2NQO2PTGS1PTGS2 | |
| SCHEMBL375017 | 0.88 | ESR1 (1.00) | ESR1ESR2NQO2PTGS1PTGS2 | |
| SCHEMBL7759808 | 0.88 | ESR1 (1.00) | ESR1ESR2NQO2PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11866584-B2 | High-refractive-index composition, high-refractive-index film, and method for manufacturing high-refractive-index film | LG CHEM, LTD. (KR) | 2024-01-09 | — | — | US | disclosed |
| US-20210095128-A1 | HIGH-REFRACTIVE-INDEX COMPOSITION, HIGH-REFRACTIVE-INDEX FILM, AND METHOD FOR MANUFACTURING HIGH-REFRACTIVE-INDEX FILM | LG CHEM, LTD. (KR) | 2021-04-01 | — | — | US | disclosed |
| WO-2020060257-A1 | HIGH-REFRACTIVE-INDEX COMPOSITION, HIGH-REFRACTIVE-INDEX FILM, AND METHOD FOR MANUFACTURING HIGH-REFRACTIVE-INDEX FILM | 주식회사 엘지화학 | 2020-03-26 | — | — | WO | disclosed |
| EP-3500627-A1 | ADDUCTS AND USES THEREOF | Huntsman Advanced Materials Americas LLC (US) | 2019-06-26 | — | — | EP | disclosed |
| EP-2726530-B1 | HYBRID EPOXY RESIN ADDUCTS | BLUE CUBE IP LLC (US) | 2018-09-12 | — | — | EP | disclosed |
| WO-2018035397-A1 | ADDUCTS AND USES THEREOF | HUNTSMAN ADVANCED MATERIALS AMERICAS LLC (US) | 2018-02-22 | — | — | WO | disclosed |
| EP-2621992-B1 | EPOXY RESIN ADDUCTS AND THERMOSETS THEREOF | BLUE CUBE IP LLC (US) | 2017-07-26 | — | — | EP | disclosed |
| US-9371414-B2 | Epoxy resin adducts and thermosets thereof | BLUE CUBE IP LLC (US) | 2016-06-21 | — | — | US | disclosed |
| US-9284434-B2 | Epoxy resin compositions | BLUE CUBE IP LLC (US) | 2016-03-15 | — | — | US | disclosed |
| EP-2621990-B1 | THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM | BLUE CUBE IP LLC (US) | 2016-02-24 | — | — | EP | disclosed |
| WO-2012044443-A1 | EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-04-05 | — | — | WO | disclosed |
| WO-2011136843-A1 | EPOXY POLYCYCLOPENTADIENE COMPOUNDS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-11-03 | — | — | WO | disclosed |
| EP-2291426-A1 | ADDUCTS OF EPOXY RESINS DERIVED FROM ALKANOLAMIDES AND A PROCESS FOR PREPARING THE SAME | Dow Global Technologies Inc. (US) | 2011-03-09 | — | — | EP | disclosed |
| US-20110046321-A1 | ADDUCTS OF EPOXY RESINS DERIVED FROM ALKANOLAMIDES AND A PROCESS FOR PREPARING THE SAME | DOW GLOBAL TECHNOLOGIES LLC | 2011-02-24 | — | — | US | disclosed |
| US-20110040046-A1 | ADDUCTS OF EPOXY RESINS AND PROCESS FOR PREPARING THE SAME | BLUE CUBE IP LLC | 2011-02-17 | — | — | US | disclosed |
| EP-2283060-A1 | ADDUCTS OF EPOXY RESINS AND PROCESS FOR PREPARING THE SAME | Dow Global Technologies Inc. (US) | 2011-02-16 | — | — | EP | disclosed |
| WO-2009143038-A1 | ADDUCTS OF EPOXY RESINS DERIVED FROM ALKANOLAMIDES AND A PROCESS FOR PREPARING THE SAME | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-11-26 | — | — | WO | disclosed |
| WO-2009142898-A1 | ADDUCTS OF EPOXY RESINS AND PROCESS FOR PREPARING THE SAME | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-11-26 | — | — | WO | disclosed |
| US-5491201-A | HEAT/CHEMICAL RESISTANCE; HIGH MECHANICAL STRENGTH | THE DOW CHEMICAL COMPANY (US) | 1996-02-13 | — | — | US | disclosed |
| US-5338828-A | Mesogenic cyclic imino ether-containing compositions and polymerization products thereof | THE DOW CHEMICAL COMPANY (US) | 1994-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046321-A1 | ADDUCTS OF EPOXY RESINS DERIVED FROM ALKANOLAMIDES AND A PROCESS FOR PREPARING THE SAME | ALKBH2, GNE, ALKBH3 | ESR1 1061/4885ESR2 838/4885NQO2 1025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.